Actinium Pharmaceuticals, Inc.
501 Fifth Avenue
New York City
New York
10017
United States
Tel: 646-459-4201
348 articles about Actinium Pharmaceuticals, Inc.
-
Actinium Pharmaceuticals, Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
7/25/2012
-
Actinium Pharmaceuticals, Inc. Successfully Completes First Cohort in Multicenter Phase I/II Leukemia Trial of Actimab-A™
7/19/2012
-
Actinium Pharmaceuticals, Inc. Launches New Website
7/12/2012
-
Actinium Pharmaceuticals, Inc. Licenses Monoclonal Antibody From Fred Hutchinson Cancer Research Center
7/11/2012
-
Actinium Pharmaceuticals, Inc. Treats First Patients in Multicenter Phase 1/2 Leukemia Trial of Actimab-A(TM)
6/13/2012
-
Actinium Pharmaceuticals, Inc. Treats First Patients in Multicenter Phase 1/2 Leukemia Trial of Actimab-A(TM)
6/13/2012
-
PacificGMP and Actinium Pharmaceuticals, Inc. Announce Agreements for cGMP Antibody Manufacturing and Stability Testing
11/20/2008
-
Actelion, Merck Enter Oral Renin Inhibitor Pact Worth Up To $272M
12/10/2003